Chemical feasibility studies of a potential coumarin-based prodrug system

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 8, 1996, Pages 945-950

  Wang, Binghe ^a,b   Zhang, Huijuan ^a   Wang, Wei ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN DERIVATIVE; ESTERASE; PRODRUG;

ARTICLE; DRUG METABOLISM; DRUG RELEASE; DRUG SYNTHESIS; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE;

EID: 0029887595     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00147-3     Document Type: Article

References (32)

1. Bundgaard, H. Design of Prodrugs; Elsevier: Amsterdam, 1985.
2. Oliyai, R.; Stella, V. J. Annu. Rev. Pharmacol. Toxicol. 1993, 32, 521.
3. Pochopin, N. L.; Charman, W. N.; Stella, V. J. Int. J. Pharmceut. 1995, 121, 157.
4. Ishikura, T.; Senou, T.; Ishihara, H.; Kato, T.; Ito, T. Int J .Pharmaceut. 1995, 116, 51.
5. Delie, F.; Letourneux, Y.; Nisato, D.; Puisieux, F.; Couvreur, P. Int. J. Pharmaceut. 1995, 115, 45.
6. Bagshawe, K. D. Drug Development Research 1995, 34, 220.
7. Smiley, J.; Benkovic, S. J. J. Am. Chem. Soc. 1995, 117, 3877.
8. Springer, C. J.; Niculescu-Duvaz, I.; Pedley, R. B. J. Med. Chem. 1994, 37, 2361.
9. Svensson, H. P.; Vrudhula, V. M.; Emswiler, J. E.; MacMaster, J. F.; Cosand, W. L.; Senter, P. D.; Wallace, P. M. Cancer Res. 1995, 55, 2357.
10. Meyer, D. L.; Law, K. L.; Payne, J. K.; Mikolajczyk, S. D.; Zarrinmayeh, H.; Jungheim, L. N.; Kling, J. K.; Shepherd, T. A.; Starling, J. J. Bioconjugate Chem. 1995, 6, 440.
11. Amsberry, K. L.; Borchardt, R. T. Pharm. Res. 1991, 8, 323.
12. Amsberry, K. L.; Gerstenberger, A. L.; Borchardt, R. T. Pharm. Res. 1991, 8, 455.
13. Bundgaard, H.; Klixbull, U.; Falch, E. Int. J. Pharmaceut. 1986, 29, 19.
14. Nielsen, N. M.; Bundgaard, H. Int. J. Pharmaceut. 1986, 29, 9.
15. Johnson, C. D.; Lane, S.; Edwards, P. N.; Taylor, P. J. J. Org. Chem. 1988, 53, 5130.
16. Amsberry, K. L.; Borchardt, R. T. J. Org. Chem. 1990, 55, 5867.
17. Ueda, Y.; Mikkilineni, A. B.; Knip, J. O.; Rose, W. C.; Casazza, A. M.; Vyas, D. M. Bioorg. Med. Chem. Lett. 1993, 3, 1761.
18. Milstein, S.; Cohen, L. A. J. Am. Chem. Soc. 1972, 94, 9158.
19. Borchardt, R. T.; Cohen, L. A. J. Am. Chem. Soc. 1972, 94, 9166.
20. Hillery, P. S.; Cohen, L. A. Bioorg. Chem. 1992, 20, 313.
21. Wang, B.; Liu, S.; Borchardt, R. T. J. Org. Chem. 1995, 60, 539.
22. Hershfield, R.; Schmir, G. L. J. Am. Chem. Soc. 1973, 95, 7359.
23. Hershfield, R.; Schmir, G. L. J. Am. Chem. Soc. 1973, 95, 8032.
24. Garrett, E. R.; Lippold, B. C.; Mielck, J. B. J. Pharm. Sci. 1971, 60, 396.
25. Lippold, B. C.; Garrett, E. R. J. Pharm. Sci. 1971, 60, 1019.
26. National Toxicology Program "Toxicology and Carcinogenesis Studies of Coumarin," U.S. Department of Health and Human Services: Public Health Service and National Institutes of Health, 1993.
27. Wattenberg, L. W.; Lam, L. K. T.; Fladmoe, A. V. Cancer Res. 1979, 39, 1651.
28. Thornes, R. D. Protective Agents in Cancer 1983, 43.
29. Tseng, A. Am. Assoc. Cancer Res. Proc. 1991, 32, Abstract No. 2257.
30. Berkarda, B.; Bouffard-Eyuboglu, H.; Dermand, U. Agents Actions 1983 ,13, 50.
31. 4N: C, 69.44; H, 5.50; N, 4.50. Found: C, 69.18; H, 5.53; N, 4.64.
32. McClelland, R. A.; Somani, R.; Kresge, A. J. Canadian J. Chem. 1979, 57, 2260.